Bortenat 2mg Injection
Bortenat 2mg Injection is a targeted chemotherapy medication containing Bortezomib, used primarily for the treatment of multiple myeloma and certain types of mantle cell lymphoma. It works by inhibiting proteasomes, which helps stop the growth of cancer cells and promotes their apoptosis (cell death).
Key Features
- Used in the treatment of multiple myeloma and mantle cell lymphoma
- Targets cancer cells by inhibiting proteasome activity
- Helps control tumor growth and proliferation
- Administered under strict medical supervision in a clinical setting
Key Ingredients
- Bortezomib 2mg
How to Use
- Administered via subcutaneous or intravenous injection as prescribed by an oncologist
- Follow the treatment schedule and dosage strictly as advised by the doctor
- Do not self-administer; use only under professional supervision
- Monitor for side effects and report any adverse reactions immediately
Precautions
- Inform your doctor about any liver, kidney, or heart conditions
- May cause low blood counts; regular blood tests are necessary
- Report any signs of infection, bleeding, or neuropathy to your doctor
- Not recommended during pregnancy or breastfeeding
- Keep out of reach of children
Legal Disclaimer
The information provided on PMC Herbals is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using this medicine. PMC Herbals does not promote self‑medication.
